136 related articles for article (PubMed ID: 34534628)
21. BORIS/CTCFL is an RNA-binding protein that associates with polysomes.
Ogunkolade BW; Jones TA; Aarum J; Szary J; Owen N; Ottaviani D; Mumin MA; Patel S; Pieri CA; Silver AR; Sheer D
BMC Cell Biol; 2013 Nov; 14():52. PubMed ID: 24279897
[TBL] [Abstract][Full Text] [Related]
22. BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells.
Janssen SM; Moscona R; Elchebly M; Papadakis AI; Redpath M; Wang H; Rubin E; van Kempen LC; Spatz A
Cell Death Discov; 2020; 6():1. PubMed ID: 32123577
[TBL] [Abstract][Full Text] [Related]
23.
Hillman JC; Pugacheva EM; Barger CJ; Sribenja S; Rosario S; Albahrani M; Truskinovsky AM; Stablewski A; Liu S; Loukinov DI; Zentner GE; Lobanenkov VV; Karpf AR; Higgins MJ
Mol Cancer Res; 2019 Oct; 17(10):2051-2062. PubMed ID: 31292201
[TBL] [Abstract][Full Text] [Related]
24. Discovering a binary CTCF code with a little help from BORIS.
Lobanenkov VV; Zentner GE
Nucleus; 2018 Jan; 9(1):33-41. PubMed ID: 29077515
[TBL] [Abstract][Full Text] [Related]
25. BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines.
Woloszynska-Read A; James SR; Song C; Jin B; Odunsi K; Karpf AR
Cancer Immun; 2010 Jul; 10():6. PubMed ID: 20649179
[TBL] [Abstract][Full Text] [Related]
26. BORIS/CTCFL epigenetically reprograms clustered CTCF binding sites into alternative transcriptional start sites.
Pugacheva EM; Bhatt DN; Rivero-Hinojosa S; Tajmul M; Fedida L; Price E; Ji Y; Loukinov D; Strunnikov AV; Ren B; Lobanenkov VV
Genome Biol; 2024 Jan; 25(1):40. PubMed ID: 38297316
[TBL] [Abstract][Full Text] [Related]
27. Testis-specific transcriptional regulators selectively occupy BORIS-bound CTCF target regions in mouse male germ cells.
Rivero-Hinojosa S; Kang S; Lobanenkov VV; Zentner GE
Sci Rep; 2017 Feb; 7():41279. PubMed ID: 28145452
[TBL] [Abstract][Full Text] [Related]
28. BORIS/CTCFL-mediated chromatin accessibility alterations promote a pro-invasive transcriptional signature in melanoma cells.
Moscona R; Janssen SM; Elchebly M; Papadakis AI; Rubin E; Spatz A
Pigment Cell Melanoma Res; 2023; 36(3-4):299-313. PubMed ID: 37082838
[TBL] [Abstract][Full Text] [Related]
29. The structural complexity of the human BORIS gene in gametogenesis and cancer.
Pugacheva EM; Suzuki T; Pack SD; Kosaka-Suzuki N; Yoon J; Vostrov AA; Barsov E; Strunnikov AV; Morse HC; Loukinov D; Lobanenkov V
PLoS One; 2010 Nov; 5(11):e13872. PubMed ID: 21079786
[TBL] [Abstract][Full Text] [Related]
30. Comparative analyses of CTCF and BORIS occupancies uncover two distinct classes of CTCF binding genomic regions.
Pugacheva EM; Rivero-Hinojosa S; Espinoza CA; Méndez-Catalá CF; Kang S; Suzuki T; Kosaka-Suzuki N; Robinson S; Nagarajan V; Ye Z; Boukaba A; Rasko JE; Strunnikov AV; Loukinov D; Ren B; Lobanenkov VV
Genome Biol; 2015 Aug; 16(1):161. PubMed ID: 26268681
[TBL] [Abstract][Full Text] [Related]
31. A polymorphic minisatellite region of BORIS regulates gene expression and its rare variants correlate with lung cancer susceptibility.
Yoon SL; Roh YG; Chu IS; Heo J; Kim SI; Chang H; Kang TH; Chung JW; Koh SS; Larionov V; Leem SH
Exp Mol Med; 2016 Jul; 48(7):e246. PubMed ID: 27416782
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies.
Hoffmann MJ; Müller M; Engers R; Schulz WA
Biochem Pharmacol; 2006 Nov; 72(11):1577-88. PubMed ID: 16854382
[TBL] [Abstract][Full Text] [Related]
33. BORIS/CTCFL-mediated transcriptional regulation of the hTERT telomerase gene in testicular and ovarian tumor cells.
Renaud S; Loukinov D; Alberti L; Vostrov A; Kwon YW; Bosman FT; Lobanenkov V; Benhattar J
Nucleic Acids Res; 2011 Feb; 39(3):862-73. PubMed ID: 20876690
[TBL] [Abstract][Full Text] [Related]
34. Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors.
Renaud S; Pugacheva EM; Delgado MD; Braunschweig R; Abdullaev Z; Loukinov D; Benhattar J; Lobanenkov V
Nucleic Acids Res; 2007; 35(21):7372-88. PubMed ID: 17962299
[TBL] [Abstract][Full Text] [Related]
35. The testis-specific factor CTCFL cooperates with the protein methyltransferase PRMT7 in H19 imprinting control region methylation.
Jelinic P; Stehle JC; Shaw P
PLoS Biol; 2006 Oct; 4(11):e355. PubMed ID: 17048991
[TBL] [Abstract][Full Text] [Related]
36. The epigenetic factor BORIS/CTCFL regulates the NOTCH3 gene expression in cancer cells.
Zampieri M; Ciccarone F; Palermo R; Cialfi S; Passananti C; Chiaretti S; Nocchia D; Talora C; Screpanti I; Caiafa P
Biochim Biophys Acta; 2014 Sep; 1839(9):813-25. PubMed ID: 24984200
[TBL] [Abstract][Full Text] [Related]
37. MAGEA1 inhibits the expression of BORIS via increased promoter methylation.
Zhao J; Wang Y; Liang Q; Xu Y; Sang J
J Cell Sci; 2019 Jan; 132(1):. PubMed ID: 30498011
[TBL] [Abstract][Full Text] [Related]
38. High expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells.
Alberti L; Renaud S; Losi L; Leyvraz S; Benhattar J
PLoS One; 2014; 9(10):e109921. PubMed ID: 25279549
[TBL] [Abstract][Full Text] [Related]
39. BORIS in human cancers -- a review.
Martin-Kleiner I
Eur J Cancer; 2012 Apr; 48(6):929-35. PubMed ID: 22019212
[TBL] [Abstract][Full Text] [Related]
40. CTCFL (BORIS) mRNA Expression in a Peripheral Giant Cell Granuloma of the Oral Cavity.
Zambrano-Galván G; Reyes-Romero M; Bologna-Molina R; Almeda-Ojeda OE; Lemus-Rojero O
Case Rep Dent; 2014; 2014():792615. PubMed ID: 25114808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]